Darrell Triulzi MD The Sickle Cell Disease Cardiovascular Risk: Red Cell Exchange Trial (SCD CARRE) Maureen Mburu, MD Nonhematopoietic Nrf2 Deficiency Worsens Chronic Intravascular Hemolysis but not Cardiomyopathy in Transgenic Sickle Cell Mice
Katherine Wood, PhD Cytochrome b5 reductase 3 is a resilience factor in mice with sickle cell disease, modifying the brain-blood axis response to ischemic stroke
Alexandra De Lille, DVM, PhD (SonoVol, Inc.)
Sossena Wood, PhD
Tomasz Brzoska, M Pharm, PhDPurinergic signaling-dependent platelet activation associated with acute versus chronic hemolysis Laura DeCastro, MD, MHScSickle Cell Disease and COVID 19 infection, an update
Managing Cardiac Metabolism to Treat Various Types of Cardiomyopathy Presented by:Konstantinos Drosatos, MSc, PhD, FAHAAssociate Professor in Pharmacology Metabolic Biology LaboratoryLewis Katz School of Medicine at Temple UniversityCenter for Translational Medicine Center for Metabolic Disease ResearchAlzheimer's Center at Temple --- This lecture is part of the Research Conference Series, co-hosted by the Vascular Medicine Institute […]
Getting to NO* the Right Heart: From Clinical Insights to Molecular Pathophysiology Presented by:Emily J. Tsai, MD, FACC, FAHAFlorence Irving Associate Professor of MedicineDivision of CardiologyCenter for Advanced Cardiac CareColumbia University Vagelos College of Physicians & Surgeons --- This lecture is part of the Research Conference Series, co-hosted by the Vascular Medicine Institute and the […]
Counter-Regulatory Immune Mechanisms in Hypertension Presented by:Matthew R. Alexander, MD, PhDAssistant Professor of MedicineDivision of Clinical PharmacologyDivision of Cardiovascular MedicineVanderbilt University Medical Center --- This lecture is part of the Research Conference Series, co-hosted by the Vascular Medicine Institute and the UPMC Heart & Vascular Institute. Please contact Anna Marie Rompala at amr208@pitt.edu for the […]
